Subgroup analysis confirmed the prognostic significance of KLRG2 high expression in patients aged > 60 years, G3 tumors, endometrioid carcinoma, and FIGO III and IV disease (Figure 3D–G). Here, KLRG2 is linked to endometrioid adenocarcinoma.